Mir-21-5p induces cell proliferation by targeting tgfbi in non-small cell lung cancer cells

35Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The mortality rate of non-small cell lung cancer (NSCLC) remains high worldwide. miR-21-5p plays an important part in many cancer types, including NSCLC. However, the effect of miR-21-5p in NSCLC tumorigenesis remains poorly understood. The present study investigated whether miR-21-5p promoted NSCLC cell proliferation in vitro. In order to study the molecular mechanism by which miR-21-5p contributes to NSCLC progression, three bioinformatics algorithms were used to predict the genes which miR-21-5p targeted. TGFBI was identfieid as a putative direct target in NSCLC cells via the luciferase reporter assay. Furthermore, miR-21-5p downregulated TGFBI protein expression by a post-transcriptional mechanism via western blotting and a reverse transcription-quantitative polymerase chain reaction analysis. Finally, TGFBI exhibited opposing effects to those of miR-21-5p on NSCLC cells, suggesting that miR-21-5p may promote cell proliferation by negative regulation of TGFBI. These results suggest miR-21-5p promote the proliferation of NSCLC cells via inhibiting TGFBI expression.

Author supplied keywords

Cite

CITATION STYLE

APA

Yan, L., Ma, J., Wang, Y., Zan, J., Wang, Z., Zhu, Y., … Zhang, Y. (2018). Mir-21-5p induces cell proliferation by targeting tgfbi in non-small cell lung cancer cells. Experimental and Therapeutic Medicine, 16(6), 4655–4663. https://doi.org/10.3892/etm.2018.6752

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free